Xiamen Amoytop Biotech Co., Ltd

Amoytop Biotech is the leading manufacturer of recombinant proteins in China, focusing on treatment of cancer and hematology, producing Molgramostim, Filgrastim, Interleukin, Interferons, by bulk and finished formula with stable quality and high purity at competitive price.

The SDA of China has granted AMOYTOP the Certificate of GMP on manufacturing GM-CSF and G-CSF with Certificate No B0272 and validation until July 04.2005.

AMOYTOP is the first and largest company to launch domestic Molgramostim in China in 1997. We are the Molgramostim Reference Standard supplier to the National Bioproduct Inspection Institute.

Activity:

- Contract Manufacturing
- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Bio
- Generics
- Pharmaceuticals / Therapeutics
- Proteins
- Reagents
- Technology

Therapeutic targets:

- Cancer
- Cardiovascular
- Hematology
- Infectious Diseases
- Oncology

Markets Covered

a. HeadQuarter: China

b. Continent(s) active: Asia , Europe , Near/Middle East , Central/South America

c. Countries active:

Corporate data:

Number of Employees: -

Turnover:

Amount:	Year:	Currency:
-	2001	US Dollar

Year founded: 1996